What Does Telemedicine Mean for the Care of Patients With Glaucoma in the Age of COVID-19?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Current perspectives in tackling glaucoma blindness.Indian journal of ophthalmology · 2025
   Review
2. Clinical analysis of infectious endophthalmitis following glaucoma filtration surgery.Journal of ophthalmic inflammation and infection · 2024
   Article
3. The causal relationship between COVID-19 and increased intraocular pressure: A bidirectional two-sample Mendelian randomization study.Frontiers in public health · 2023
   Article
4. How glaucoma care changed for the better after the pandemic.Current opinion in ophthalmology · 2022
   Review
5. Assessing optometric care delivered by telehealth during the COVID-19 public health emergency.Therapeutic advances in ophthalmology
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as